Innoveren Scientific Inc (IVRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 454 | 1,612 | 2,151 | 8,347 | 7,883 |
| Cost of Goods | 118 | 705 | 767 | 2,053 | 2,367 |
| Gross Profit | 336 | 907 | 1,384 | 6,294 | 5,517 |
| Operating Expenses | 5,559 | 6,897 | 9,243 | 36,905 | 10,075 |
| Operating Income | -5,106 | -5,286 | -7,092 | -30,558 | -4,192 |
| Interest Expense | 3,501 | 177 | 1,463 | 299 | 184 |
| Other Income | -1,693 | 663 | 2,096 | 1,050 | -18 |
| Pre-tax Income | -10,300 | -4,799 | -6,459 | -29,808 | -4,394 |
| Net Income Continuous | -10,300 | -4,799 | -6,459 | -29,808 | -4,394 |
| Net Income | $-10,300 | $-4,799 | $-6,459 | $-29,808 | $-4,394 |
| EPS Basic Total Ops | -35.06 | -32.93 | -60.00 | -340.00 | -130.00 |
| EPS Basic Continuous Ops | -35.03 | -32.87 | -57.94 | -309.30 | -130.54 |
| EPS Diluted Total Ops | -35.06 | -32.93 | -60.00 | -340.00 | -130.00 |
| EPS Diluted Continuous Ops | -35.03 | -32.87 | -57.94 | -309.30 | -130.54 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -60.00 | -340.00 | -230.00 |
| EBITDA(a) | $-5,591 | $-5,270 | $-5,616 | $-29,572 | $-4,097 |